MycoMedica Life Sciences Overview
- Year Founded
-
2021
- Status
-
Private
- Employees
-
20
- Latest Deal Type
-
Later Stage VC
- Latest Deal Amount
-
$15M
- Investors
-
14
MycoMedica Life Sciences General Information
Description
Developer of psilocybin-based medications designed to treat mental health and neurodegenerative disorders. The company engages in the study of different fungal allies and their usage for human benefits in the prevention and treatment of psychiatric and neurological disorders, enabling medical professionals to fuel fungi-based drug development.
Contact Information
Website
www.mycomedica.comCorporate Office
- 50 Southeast Nelson Road
- Shelton, WA 98584-7217
- United States
Corporate Office
- 50 Southeast Nelson Road
- Shelton, WA 98584-7217
- United States
MycoMedica Life Sciences Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 4. Later Stage VC | 14-Aug-2026 | $15M | Completed | Generating Revenue | ||
| 3. Secondary Transaction - Private | Completed | Generating Revenue | ||||
| 2. Early Stage VC (Series A) | 08-Apr-2022 | $55.9M | $63.3M | Completed | Generating Revenue | |
| 1. Seed Round | 27-Dec-2021 | $7.39M | $7.39M | Completed | Generating Revenue |
MycoMedica Life Sciences Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series A-1 | ||||||||
| Series A | ||||||||
| Seed | 1,139,891 | $0.000100 | $6.99 | $6.99 | 1x | $6.99 | 8.38% |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Opportunity Score
Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.
Exit Type
Evaluates the likelihood of a successful exit for investors, and the most likely exit type.
MycoMedica Life Sciences Comparisons
Industry
Financing
Details
MycoMedica Life Sciences Competitors (77)
One of MycoMedica Life Sciences’s 77 competitors is Neurelis, a Venture Capital-Backed company based in San Diego, CA.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Neurelis | Venture Capital-Backed | San Diego, CA | ||||
| Cerecin | Venture Capital-Backed | Broomfield, CO | ||||
| Aquinnah | Venture Capital-Backed | Cambridge, MA | ||||
| Centrose | Venture Capital-Backed | Madison, WI | ||||
| NeuroNascent | Venture Capital-Backed | Clarksville, MD |
MycoMedica Life Sciences Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
MycoMedica Life Sciences Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
MycoMedica Life Sciences Investors (14)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| ARTIS (San Francisco) | Venture Capital | Minority | ||
| Bicycle Day Ventures | Angel Group | Minority | ||
| Bridge Builders Collaborative | Venture Capital | Minority | ||
| Evolve Ventures | Venture Capital | Minority | ||
| Angel (individual) | Minority |
MycoMedica Life Sciences FAQs
-
When was MycoMedica Life Sciences founded?
MycoMedica Life Sciences was founded in 2021.
-
Where is MycoMedica Life Sciences headquartered?
MycoMedica Life Sciences is headquartered in Shelton, WA.
-
What is the size of MycoMedica Life Sciences?
MycoMedica Life Sciences has 20 total employees.
-
What industry is MycoMedica Life Sciences in?
MycoMedica Life Sciences’s primary industry is Drug Discovery.
-
Is MycoMedica Life Sciences a private or public company?
MycoMedica Life Sciences is a Private company.
-
What is MycoMedica Life Sciences’s current revenue?
The current revenue for MycoMedica Life Sciences is .
-
How much funding has MycoMedica Life Sciences raised over time?
MycoMedica Life Sciences has raised $78.3M.
-
Who are MycoMedica Life Sciences’s investors?
ARTIS (San Francisco), Bicycle Day Ventures, Bridge Builders Collaborative, Evolve Ventures, and are 5 of 14 investors who have invested in MycoMedica Life Sciences.
-
Who are MycoMedica Life Sciences’s competitors?
Neurelis, Cerecin, Aquinnah, Centrose, and NeuroNascent are some of the 77 competitors of MycoMedica Life Sciences.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
